alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| 1. | I      have reviewed this Annual Report on Form 10-K/A of      SourceForge, Inc.; and |
|----|-------------------------------------------------------------------------------------------------|

| 2. | Based      on my knowledge, this report does not contain any untrue statement of a      material fact or omit to state a material fact necessary to make the      statements made, in light of the circumstances under which such statements      were made, not misleading with respect to the period covered by this      report. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  June      10, 2009 | By:    | /s/ Scott L. Kauffman                      |
|-------------------------------------|-----------------------|--------------------------------------------|
|                                |                  | Scott L.    Kauffman                       |
|                                |                  | President and Chief Executive      Officer |

----
#### SWEETEN v. KING

No. 227 PC.

Case below: 29 N.C. App. 672.

Petition by plaintiffs and petition by defendants for discretionary review under G.S. 7A-31 denied 1 September 1976.
[Federal Register Volume 72, Number 199 (Tuesday, October 16, 2007)]
[Notices]
[Page 58673]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-5091]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; R13 Conference Review.
    Date: October 31, 2007.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Ellen S. Buczko, PhD., Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2676, 
<a href="/cdn-cgi/l/email-protection#24414651475e4f4b15644a4d454d400a4a4d4c0a434b52"><span class="__cf_email__" data-cfemail="e88d8a9d8b928387d9a8868189818cc6868180c68f879e">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5091 Filed 10-15-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Electronically Filed

Intermediate Court of Appeals

CAAP-16-0000848

30-SEP-2019

07:57 AM
EXHIBIT 11

COMPUTATION OF EARNINGS (LOSS) PER SHARE
                                           ASSUMING              ASSUMING
                                       PRIMARY DILUTION        FULL DILUTION
                                                                        
                                      Thirteen Weeks Ended  Thirteen Weeks Ended
                                       Jan 25,   Jan 27,      Jan 25,   Jan 27,
                                        1997       1996        1997       1996  
                                                                        
       (In thousands, except per share amounts)



AVERAGE SHARES OUTSTANDING

  1  Average shares outstanding           10,754   10,754       10,754   10,754
  2  Net additional shares outstanding
      assuming exercise of stock options     -        -            -         74
  3  Average number of common shares
      outstanding                         10,754   10,754       10,754   10,828

EARNINGS (LOSSES)

  4  Loss from continuing      
      operations                         $(1,223) $(2,348)      (1,223)  $2,348)

  5  Net loss                            $(1,223) $(2,316)     $(1,223) $(2,316)

PER SHARE AMOUNTS

     Loss from continuing         
      operations (line 4 / line 3)       $ (.11)  $ (.22)      $ (.11)  $  (.22)
                                                                            (a)
     Net loss         
      (line 5 / line 3)                  $ (.11)  $ (.22)      $ (.11)  $  (.22)



  NOTE 1 - In  all years, earnings  per share was  calculated using the
  treasury stock method.

  (a)  Amount is  anti-dilutive; accordingly,  primary  earningsper share 
       is disclosed for reporting purposes in accordance with generally 
       accepted accounting principles.
#### SNELLINGS v. ROBERTS

No. 70 PC.

Case below: 12 N.C. App. 476.

Petition for writ of certiorari to North Carolina Court of Appeals denied 14 December 1971.
# C_2011286EN.01001301.xml

| 30.9.2011 | EN | Official Journal of the European Union | C 286/13 |
| --------- | -- | -------------------------------------- | -------- |

---

Winding-up proceedings

Decision to open winding-up proceedings in respect of FARO Compagnia di Assicurazioni e Riassicurazioni SpA

(Publication in accordance with Article 14 of Directive 2001/17/EC of the European Parliament and of the Council on the reorganisation and winding-up of insurance undertakings)

2011/C 286/05

| Insurance undertaking | FARO Compagnia di Assicurazioni e Riassicurazioni SpA Viale Parioli 1/3 00197 Roma RM ITALIA | FARO Compagnia di Assicurazioni e Riassicurazioni SpA | Viale Parioli 1/3 | 00197 Roma RM | ITALIA |
| ----------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------- | -------------------- | ------------- | ------ |
| FARO Compagnia di Assicurazioni e Riassicurazioni SpA | | | | | |
| Viale Parioli 1/3 | | | | | |
| 00197 Roma RM | | | | | |
| ITALIA | | | | | |
| Date, entry into force and nature of the decision | Decree of the Minister for Economic Development of 28 July 2011 — withdrawal of authorisation to carry out activities in all branches and compulsory liquidation of FARO Compagnia di Assicurazioni e Riassicurazioni SpA | | | | |
| Competent authorities | Ministry of Economic Development Via Molise 2 00187 Roma RM ITALIA | Ministry of Economic Development | Via Molise 2 | 00187 Roma RM | ITALIA |
| Ministry of Economic Development | | | | | |
| Via Molise 2 | | | | | |
| 00187 Roma RM | | | | | |
| ITALIA | | | | | |
| Supervisory authority | ISVAP Via del Quirinale 21 00187 Roma RM ITALIA | ISVAP | Via del Quirinale 21 | 00187 Roma RM | ITALIA |
| ISVAP | | | | | |
| Via del Quirinale 21 | | | | | |
| 00187 Roma RM | | | | | |
| ITALIA | | | | | |
| Appointed liquidator | Avv. Andrea Grosso Via Malpighi 9 00161 Roma RM ITALIA Tel. +39 068079767 Piazza Piccapietra 73/1 16121 Genova GE ITALIA Tel. +39 0108595001 Fax +39 0108595005 | Avv. Andrea Grosso | Via Malpighi 9 | 00161 Roma RM | ITALIA |
| Avv. Andrea Grosso | | | | | |
| Via Malpighi 9 | | | | | |
| 00161 Roma RM | | | | | |
| ITALIA | | | | | |
| Tel. +39 068079767 | | | | | |
| Piazza Piccapietra 73/1 | | | | | |
| 16121 Genova GE | | | | | |
| ITALIA | | | | | |
| Tel. +39 0108595001 | | | | | |
| Fax +39 0108595005 | | | | | |
| Applicable law | Article 245 of Legislative Decree No 209/2005 | | | | |

By the Decree of the Minister for Economic Development of 28 July 2011, the authorisation of FARO Compagnia di Assicurazioni e Riassicurazioni SpA, of Rome, Viale Parioli 1/3, to carry out activities in all branches has been withdrawn within the meaning of Article 245 of Legislative Decree No 209 of 7 September 2005, and compulsory liquidation ordered.

---
# C_2011169EN.01000901.xml

| 9.6.2011 | EN | Official Journal of the European Union | C 169/9 |
| --- | --- | --- | --- |

9.6.2011

EN

Official Journal of the European Union

C 169/9

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 1857/2006 on the application of Articles 87 and 88 of the Treaty to State aid to small and medium-sized enterprises active in the production of agricultural products and amending Regulation (EC) No 70/2001

2011/C 169/04

Aid No: SA.33066 (11/XA)

Member State: Spain

Region: Comunidad Valenciana

Title of aid scheme or name of company receiving an individual aid: Prestación de servicios a los productores lácteos valencianos que sean PYMES, con objeto de fomentar la producción de leche de calidad

Legal basis: Resolución de 2011, de la Consellera de Agricultura, Pesca y Alimentación, por la que se concede una subvención nominativa al Laboratorio Interprofesional Lacteo de la Comunidad Valenciana

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: Annual overall amount of the budget planned under the scheme: EUR 0,02 million

Maximum aid intensity: 100 %

Date of implementation: —

Duration of scheme or individual aid award: 28 May 2011-31 December 2011

Objective of aid: Production of quality agricultural products (Article 14 of Regulation (EC) No 1857/2006)

Sector(s) concerned: Raising of dairy cattle, Raising of sheep and goats

Name and address of the granting authority:

| Dir. Gral. Prod. Agraria |
| --- |
| Conselleria Agricultura, Pesca y Alimentación |
| C/ Amadeo de Saboya, 2 |
| 46010 Valencia |
| ESPAÑA |

Dir. Gral. Prod. Agraria

Conselleria Agricultura, Pesca y Alimentación

C/ Amadeo de Saboya, 2

46010 Valencia

ESPAÑA

Website: http://www.agricultura.gva.es/web/c/document_library/get_file?uuid=300e7982-c128-4d23-b6b2-a36f3e992245&groupId=16

Other information: —

---
Exhibit 16.1  Securities and Exchange Commission 100 F Street, N.E. Washington, D.C., USA 20549-7561  Dear Sirs/Madams,  We have read Luxfer Holdings PLCs disclosure pursuant to Item 16F of Form 20-F as set out in the section entitled Change in Registrants Certifying Accountant on pages 148 and 149 of Luxfer Holdings PLCs Annual Report on Form 20-F for the year ended December 31, 2015.  We agree with the statements made in the first and second paragraphs therein.  We have no basis on which to agree or disagree with other statements of the registrant contained therein.  Yours faithfully,/s/ Ernst & Young LLPManchester, EnglandMarch 15, 2016
EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Asia4sale.com, Inc. (the Company) on Form 10-KSB for the period ending December 31, 2004, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Eric Montandon, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

|(1) |  | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------

|(2) |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company.
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------

/s/ Eric Montandon

Eric Montandon

Chief Executive Officer and Chief Financial Officer

January 30, 2006

This certification accompanies this Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by Registrant for the purposes of §18 of the Securities Exchange Act of 1934, as amended. This certification shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Report), irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by §906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 1 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 2 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 3 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 4 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 5 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 6 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 7 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 8 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 9 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 10 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 11 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 12 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 13 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 14 of 15
Case 1:07-cv-03498-AKH Document 1 Filed 05/02/2007 Page 15 of 15
Case 1:05-cv-04950-MBM Document 11 Filed 12/01/2005 Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       1,180,833
<SECURITIES>                                         0
<RECEIVABLES>                                  104,482
<ALLOWANCES>                                   (53,885)
<INVENTORY>                                     54,589
<CURRENT-ASSETS>                             1,363,843
<PP&E>                                         949,505
<DEPRECIATION>                                (126,284)
<TOTAL-ASSETS>                              10,970,767
<CURRENT-LIABILITIES>                        1,321,707
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        23,051
<OTHER-SE>                                   9,228,033
<TOTAL-LIABILITY-AND-EQUITY>                10,970,767
<SALES>                                      1,364,694
<TOTAL-REVENUES>                             1,364,694
<CGS>                                        1,137,223
<TOTAL-COSTS>                                1,137,223
<OTHER-EXPENSES>                             5,085,546
<LOSS-PROVISION>                                74,000
<INTEREST-EXPENSE>                              64,133
<INCOME-PRETAX>                             (4,996,208)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (4,996,208)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (4,996,208)
<EPS-BASIC>                                      (0.34)
<EPS-DILUTED>                                    (0.34)


</TABLE>
<PAGE>   1
                                                                      EXHIBIT 11

                              THE FIRST YEARS INC.
                        PRIMARY NET INCOME PER SHARE AND
                       FULLY DILUTED NET INCOME PER SHARE


<TABLE>
<CAPTION>
                                                 Three Months Ended
                                                 ------------------
                                                      March 31,
                                                      ---------
                                                1997             1996
                                             ----------       ----------
<S>                                          <C>              <C>       
PRIMARY NET INCOME PER SHARE

Net income available for common shares
and common stock equivalent shares           $1,666,502       $1,186,573
                                             ----------       ----------

 Primary net income per share                $     0.32       $     0.25
                                             ----------       ----------

SHARES USED IN COMPUTATION

Weighted average common shares
outstanding                                   4,950,701        4,515,487

Common stock equivalents - options              185,310          173,939
                                             ----------       ----------
Total common stock and common
stock equivalent dilutive shares              5,136,011        4,689,426
                                             ==========       ==========


FULLY DILUTED NET INCOME PER SHARE

Net income available for common shares
and common stock equivalent shares           $1,666,502       $1,186,573
                                             ----------       ----------

 Fully diluted net income per share          $     0.32       $     0.25
                                             ----------       ----------

SHARES USED IN COMPUTATION

Weighted average common shares
outstanding                                   4,950,701        4,515,487

Common stock equivalents - options              185,310          202,600
                                             ----------       ----------
Total common stock and common
stock equivalent dilutive shares              5,136,011        4,718,087
                                             ==========       ==========
</TABLE>


                                     Page 9
**EXHIBIT 12.1**

 

**Certification Pursuant to Section 906 of theSarbanes-Oxley Act 2002**

 

I,Bryan Needham, director of ONO Finance PLC, certify that to the best of myknowledge (i) the Form 20-F fully complies with the requirements of Section13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the informationcontained in the Form 20-F fairly presents, in all material respects, thefinancial condition and results of operations of ONO Finance PLC.
| By:   /s/ Bryan Needham |               |
|------------------------------|--------------------|
| **Name:**                    | **Bryan  Needham** |   |
| **Title:**                   | **Director**       |   |
| **Date:**                    | **May 29,  2003**  |   |

 

 

----
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   DEC-31-1999
<CASH>                                         101,657,000
<SECURITIES>                                   0
<RECEIVABLES>                                  4,653,000
<ALLOWANCES>                                   408,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               108,206,000
<PP&E>                                         34,203,000
<DEPRECIATION>                                 5,654,000
<TOTAL-ASSETS>                                 137,677,000
<CURRENT-LIABILITIES>                          12,891,000
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       322,000
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   137,677,000
<SALES>                                        6,615,000
<TOTAL-REVENUES>                               6,615,000
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               39,843,000
<LOSS-PROVISION>                               958,000
<INTEREST-EXPENSE>                             3,351,000
<INCOME-PRETAX>                                35,971,000
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            35,971,000
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   35,971,000
<EPS-BASIC>                                    2.49
<EPS-DILUTED>                                  2.49


</TABLE>
Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

UNITED STATES OF AMERICA

 

vs. Case No. 3:10cr8/MCR

WILLIE C. WILLIAMS

_____________________________________________________________________

REPORT AND RECOMMENDATION

CONCERNING PLEA OF GUILTY

The Defendant, by consent, has appeared before me pursuant to Rule 11, Fed. R. Crim. P.,

and has entered a plea of guilty to Count I of the Indictment. After cautioning and examining the

Defendant under oath concerning each of the subjects mentioned in Rule 11, I determined that the

guilty plea was knowing and voluntary, and that the offense charged is supported by an independent

basis in fact containing each of the essential elements of such offense. I therefore recommend that

the plea of guilty be accepted and that the Defendant be adjudicated guilty and have sentence

imposed accordingly.

Dated: February 24, 2010 /s/ Elizabeth M. Timothy 

ELIZABETH M. TIMOTHY

UNITED STATES MAGISTRATE JUDGE
Page 2 of 2

NOTICE

Any objections to these proposed findings and recommendations must be filed within

twenty four (24) hours after being served a copy thereof. Any different deadline that may

appear on the electronic docket is for the court’s internal use only, and does not control. A

copy of objections shall be served upon all other parties. Failure to object may limit the scope

of appellate review of factual findings. See 28 U.S.C. § 636; United States v. Roberts, 858 F.2d

698, 701 (11th Cir. 1988).

Case No. 3:10cr8/MCR